Covered recipient · General Payments record
JOSEPHINE V DAVIS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2025
$273.91
- Reported across 17 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $166.31 | 10 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $33.48 | 2 |
| Novo Nordisk AS | $31.94 | 2 |
| Amgen Inc. | $29.33 | 2 |
| Medtronic, Inc. | $19.72 | 1 |
| Merck Sharp & Dohme Corporation | $18.74 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.20 | 1 |
| Acerta Pharma LLC | $14.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.68 | 10/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228521016 | CMS |
| Amgen Inc. | $13.65 | 10/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227099890 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.90 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206638711 | CMS |
| Lilly USA, LLC | $16.58 | 01/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186669979 | CMS |
| Lilly USA, LLC | $16.90 | 09/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186699779 | CMS |
| Medtronic, Inc. | $19.72 | 01/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219993027 | CMS |
| Merck Sharp & Dohme LLC | $18.74 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238373251 | CMS |
| Novartis Pharmaceuticals Corporation | $18.20 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200176700 | CMS |
| Novo Nordisk Inc | $15.97 | 03/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188524615 | CMS |
| Novo Nordisk Inc | $15.97 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188300164 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2021, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.